Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $61.6 million.

  • Bio's Liabilities and Shareholders Equity rose 1616.68% to $61.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.9 million, marking a year-over-year increase of 1134.15%. This contributed to the annual value of $86.6 million for FY2024, which is 1091.89% up from last year.
  • Latest data reveals that Bio reported Liabilities and Shareholders Equity of $61.6 million as of Q3 2025, which was up 1616.68% from $67.5 million recorded in Q2 2025.
  • Over the past 5 years, Bio's Liabilities and Shareholders Equity peaked at $94.4 million during Q2 2023, and registered a low of $51.3 million during Q2 2022.
  • Its 5-year average for Liabilities and Shareholders Equity is $70.2 million, with a median of $68.8 million in 2021.
  • Per our database at Business Quant, Bio's Liabilities and Shareholders Equity surged by 8387.0% in 2023 and then tumbled by 3928.33% in 2024.
  • Bio's Liabilities and Shareholders Equity (Quarter) stood at $62.5 million in 2021, then increased by 8.49% to $67.9 million in 2022, then increased by 15.02% to $78.0 million in 2023, then increased by 10.92% to $86.6 million in 2024, then decreased by 28.86% to $61.6 million in 2025.
  • Its Liabilities and Shareholders Equity was $61.6 million in Q3 2025, compared to $67.5 million in Q2 2025 and $77.3 million in Q1 2025.